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Background: The mosquito transmitted Dengue virus (DENV) remains a significant public health problem in many
tropical and subtropical countries. Increasing evidence has suggested that during the infection process cellular lipids
play important roles at several stages of the replication cycle. This study sought to characterize the changes in lipid
metabolism gene expression and investigated the role of one enzyme, fatty acid synthase, in DENV infection.
Methods: Transcriptional profiles of genes associated with lipid metabolism were evaluated by real-time PCR after
infection of different cell lines (HepG2 and HEK293T/17) and with different DENVs (laboratory adapted and low
passage). Expression profiles of genes were evaluated by western blotting. A critical lipid metabolism protein, fatty acid
synthase was down-regulated through siRNA and inhibited with orlistat and the effect on DENV infection determined
by flow cytometry, plaque assay, western blotting and confocal microscopy.
Results: The results showed alterations of gene transcription and expression were seen in genes variously associated
with lipogenesis, lipolysis and fatty acid β-oxidation during DENV infection. Interference of fatty acid synthase with
either siRNA or orlistat had marked effects on virus production, with orlistat having an EC50 value of 10.07 μM at 24 h
post infection. However, non-structural protein expression was largely unaffected.
Conclusions: While drug treatment reduced virus titer by up to 3Log10, no significant effect on DENV non-structural
protein expression was observed, suggesting that fatty acid synthase acts through an effect on virion formation.
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Each year there are believed to be nearly 400 million
new Dengue virus (DENV) infections in tropical and
sub-tropical countries worldwide, of which some 100
million show some form of symptom [1]. The mosquito
transmitted DENV infects humans after the bite of an
infected female Aedes mosquito, and where symptoms
occur these can range from a mild flu-like illness to a se-
vere life threatening syndrome primarily characterized
by plasma leakage [2]. DENV is largely maintained in an
urban transmission cycle, with the anthropophilic Aedes* Correspondence: duncan_r_smith@hotmail.com
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four closely related viruses, DENV 1 to 4, and while in-
fection with one virus results in the induction of a ro-
bust protective immune response against the infecting
virus [4], only transient or no immunity is offered
against infection with a heterotypic virus, and repeated
infections with heterotypic viruses can occur [5]. In
many cases, second infections are associated with a
more severe presentation as a consequence of interplay
between the host immune response raised by the first in-
fection and the second heterotypic virus [6].
The virus is believed to initially replicate in skin
resident dendritic cells, after which transmission of the
virus around the body can result in the involvement of a
wide range of cell types including monocytes andle is distributed under the terms of the Creative Commons Attribution 4.0
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sor cells [9], liver cells [10] and endothelial cells [11]. In-
ternalization of the virus to a host cell is believed to
occur by endocytosis of the virus via clathrin coated pits
after receptor binding [12], although alternate pathways
have been proposed [13, 14]. The DENV genome, a sin-
gle stranded positive sense RNA molecule encoding a
single open reading frame is directly translated as a sin-
gle polypeptide that undergoes processing by viral and
host proteases to generate the three structural proteins
(envelope (E), pre-membrane (prM) and capsid proteins)
and the seven non structural proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B and NS5) that form the repli-
cation complex [2]. The replication complex directs the
production of the full length positive sense genome and
the newly synthesized genomic RNA is packaged by the
capsid protein forming a nucleocapsid complex [15].
The nucleocapsid buds from the ER and becomes envel-
oped by a lipid membrane in which are embedded the
newly synthesized E and prM proteins. As a conse-
quence of this process, nearly 20% of the weight of the
dengue virion is lipid [16].
Despite the virus particle having significant lipid content
[16], this aspect of DENV pathobiology is only recently
being explored. A comprehensive analysis undertaken in
insect cells showed that infection resulted in extensive re-
modeling of the lipid profile, in particular with respect to
alterations in the levels of lipids that were associated with
altering membrane bilayer curvature or permeability [17].
In mammalian cells it is known that virus entry is
associated with the expression of receptors associated
with lipid rafts [18], and that cholesterol required for
infection [19]. DENV infection results in significant
remodeling of membranes to provide structures for the
replication complex [20], as well as possibly shielding the
replication complex from the host cellular innate immune
system [21]. Given the extensive membrane re-model-
ing in mammalian cells (as with insect cells), it is
likely that the mammalian cell lipid profile is also re-
engineered to support DENV replication. It is known
that β-oxidation is increased in DENV infected cells
[22], and it has been proposed that the main conse-
quence of the activation of autophagy in DENV infec-
tion [23, 24] is to increase β-oxidation to provide
energy for DENV replication [22]. Consistent with
this, the re-localization of fatty acid synthase (FASN;
a critical rate limiting enzyme in lipid biosynthesis) to
the replication complex by interaction with DENV
NS3 has been reported [25, 26].
This study sought to determine whether lipid metabol-
ism associated gene expression is altered in mammalian
cells upon DENV infection, as well as to determine
whether targeting proteins involved in lipid metabolism
affects the DENV replication cycle. The study showedthat the expression of lipid associated genes is altered
during DENV infection, and that FASN is a suitable tar-
get for therapeutic intervention.
Methods
Cell lines and viruses
HEK293T/17 (Human Embryonic Kidney) and HepG2
(Human hepatocellular liver carcinoma) cells were main-
tained in Dulbecco’s modified eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and
100 units of penicillin/streptomycin per ml. LLC-MK2
(Rhesus monkey kidney epithelial) cells were grown in
the same medium containing 5% FBS and 100 units/ml
of penicillin/streptomycin. All cultures were grown at
37 °C in a 5% CO2 humidified incubator. DENV 2 (strain
16681) DENV 4 (strain 1036) or DENV-4DHF (Gene-
Bank accession number KM519592) were as described
previously [27]. Viruses were propagated in C6/36 cells
and virus titers were determined by standard plaque
assay as described previously [28]. Virus infection with
was undertaken as described previously [28] in the pres-
ence or absence of orlistat (Sigma-Aldrich, St Louis,
MO).
Oil red O staining
Mock infected or DENV 2 infected HEK293T/17 or
HepG2 cells were grown under standard conditions in
six well plates for 24 h following which the cells were
fixed by the addition of 1 ml of 10% formalin followed
by 1 ml of 60% isopropanol for 10 min. The cells were
stained with Oil Red O (Sigma-Aldrich), washed with
distilled water 4 times before oil red O was eluted from
the cells by the addition of 1 ml of 100% isopropanol for
15 min and the absorbance of the solution measured by
spectrophotometry at 490 nm. Experiments were under-
taken independently in triplicate. For visualization of oil
red droplets, the experiment was repeated with cells
grown on glass coverslips (without elution of Oil Red
O), followed by observation under bright field of a Carl
Zeiss LSM800.
Real time PCR
HEK293T/17 or HepG2 cells were mock infected or in-
fected at m.o.i 5 (DENV 2) or at m.o.i 20 (DENV 4 and
DENV-4DHF) and incubated for 24 h under standard
conditions, after which time total RNA was extracted
using Tri-Reagent (Molecular Research Center, Cincin-
nati, OH) and treated with DNase for 1 h followed by
re-extraction with Tri-Reagent. 1 μg of total RNA was
reverse transcribed to cDNA using Improm-п™ reverse
transcriptase (Promega, Madison, WI) and oligo (dT)
(Bio Basic, Inc.). Quantitative real time PCR was under-
taken using the KAPA SYBR FAST qPCR Kit 2X Master
MIX (Kapa Biosystems Inc, Wilmington, MA) in a
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cation using gene specific primers (Additional file 1:
Table S1) was carried out at 95 °C for an initial 3 min
period followed by 40 cycles of denaturation at 95 °C for
10s, annealing at 60 °C for 30s and extension at 72 °C
for 20s. Transcripts examined included those for fatty
acid synthase (FASN), adipose triglyceride lipase (ATGL)
gene, peroxisome proliferator-activated receptor alpha
(PPARα), diglyceride acyltransferase 1 (DGAT1), acetyl-
CoA carboxylase alpha 1 (ACC1), Fatty acyl CoA oxidase
(AOX), Carnitine palmitoyltransferase I (CPT1),
Medium-chain acyl-CoA dehydrogenase (MCAD), sterol
regulatory element-binding protein-1c (SREBP1c), stear-
oyl-CoA desaturase 1 (SCD1) and actin. Experiments
were performed independently in triplicate.
siRNA gene silencing
siRNA templates were designed from target sites on the
human fatty acid synthase gene (GenBank accession
number NM_004104) and the green fluorescent protein
(GFP; GenBank accession number U50974) using the
online tool from Ambion, Austin, TX (http://www.ambion.-
com/techlib/misc/siRNA_finder.html). The sequences were
subjected to siRNA template design to generate DNA oli-
gonucleotides sequences for the Silencer siRNA Construc-







siRNA transfection and infection
HEK293T/17 cells were maintained in antibiotic free
medium and transfected using lipofectamine RNAiMAX
(Invitrogen,Carlsbad, CA) by reverse transfection follow-
ing the manufacturers protocol using 250 pmol siRNA
and 2.5 μl of lipofectamine RNAiMAX. The cells were
cultured under standard conditions for 24 h. At 24 h
post-transfection, transfected and mock transfected cells
were infected with DENV 2 m.o.i 5 for 2 h. After that,
uninternalized viruses were inactivated by an acid glycine
wash as described previously [28]. At 24 and 48 h post
transfection, supernatants and cells were collected for ana-
lysis by plaque assay and flow cytometry, respectively.
Cytotoxicity assessment
Cytotoxicity of orlistat was evaluated using the Vybrant®
MTT Cell Proliferation Assay Kit according to the man-
ufacturers’ recommendation. Cytotoxicity was evaluated
at 24 and 36 h at 10, 50 and 100 μM. In addition, cellmorphology was assessed under an inverted light
microscope.
Flow cytometry
Infected and mock infected cells were collected by cen-
trifugation and blocked with 10% normal goat serum
and incubated on ice for 30 min following which the
cells were fixed with 4% paraformaldehyde and incu-
bated at room temperature in the dark for 20 min and
then permeabilized with 0.2% saponin for 10 min. The
cells were washed with 1% BSA in PBS and centrifuged
at 6,000 g for 5 min. Cells were resuspended and incu-
bated overnight at 4 °C with an anti-dengue virus com-
plex mouse monoclonal antibody (Merck Millipore,
Billerica, MA). Subsequently cells were incubated with a
FITC conjugated goat anti-mouse IgG antibody (Thermo
Scientific Inc, Rockford, IL). Finally, the cells were resus-
pended in PBS and were analyzed on a BD FACalibur
cytometer (Becton Dickinson, BD Biosciences, San Jose,
CA, USA) and data analyzed using CELLQuestTM
software.
Immunofluorescence and confocal imaging
Immunofluorescence was undertaken essentially as de-
scribed previously [24]. HEK293T/17 cells grown on
glass cover slips were mock infected or infected with
DENV 2 m.o.i 5 for 2 h at 4 °C with or without treat-
ment of the cells with compound as indicated. After the
appropriate time period cells were washed twice washed
with PBS for 5 min and were subsequently perme-
abilized with 0.3% TritonX-100 in PBS for 10 min and
then washed twice with 0.03% TritonX-100 in PBS. Cells
were subsequently incubated with a 1:50 dilution of a
rabbit polyclonal anti-dengue NS1 antibody (Thermo
Scientific Inc.) at 4 °C overnight, after which cells were
washed three times with 0.03% TritonX-100 in PBS for
5 min each time, followed by incubation with a 1:100 di-
lution of a rhodamine red X-conjugated goat anti-rabbit
IgG antibody (Jackson ImmunoResearch Laboratories)
and a 1:500 dilution of DAPI (Molecular Probes) for 1 h.
Finally, the cells were washed with 0.03% TritonX-100 in
PBS and the cover slips were mounted onto glass slides
using Prolong® Gold antifade reagent (Invitrogen). Sig-
nals were observed under an Olympus FluoView 1000
confocal microscope (Olympus Corporation, Shinjuku-
ku, Tokyo, Japan) equipped with Olympus FluoView
Software v. 1.6. For colocalization analysis, the same
protocol was used, but the primary antibody incubation
was undertaken with a 1:50 dilution of a rabbit mono-
clonal anti-DENV NS3 protein antibody (Thermo Fisher
Scientific) and a 1:50 dilution of a mouse monoclonal
anti-fatty acid synthase (FASN) antibody (Santa Cruz
Biotechnology Inc.). Secondary antibodies were a Rhoda-
mine red- conjugated goat anti-rabbit IgG (Thermo
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anti-mouse IgG (Molecular Probes). Cells were addition-
ally stained with DAPI (Moleclar Probes).
Western blot analysis
Mock infected or DENV 2 infected HEK293T/17 cells,
either untreated or treated with compound as appropri-
ate were lysed with RIPA buffer (1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS in PBS) and the lysates
were sonicated twice for 5 min at 4 °C. The cell lysates
were then centrifuged at 10,000 x g for 10 min andFig. 1 Observation and quantification of neutral lipids by Oil red O staining
HepG2 cells cultured on glass microscope cover slips for 24 h were stained
LSM800 microscope. Oil droplets show as black circles. The smaller drople
grown in six well plates for 24 and 36 h and Oil red O was subsequently el
undertaken independently in triplicate. Bars show mean +/−SD (*; p valuesupernatants were collected. Equal amounts of protein
(80 μg) were separated on 10% SDS-polyacrylamide gels
and were transferred to nitrocellulose membranes using
a Trans-Blot electrophoretic transfer cell (Bio-Rad La-
boratories, Richmond, CA). The membranes were
blocked with 5% skim milk in TBS for 2 h at room
temperature before incubation with appropriate primary
antibodies, namely a 1:500 dilution of a mouse monoclo-
nal pan specific anti-dengue virus antibody (Santa Cruz
Biotechnology), a 1:1,000 dilution of a rabbit monoclonal
anti-dengue NS3 antibody (Thermo Fisher Scientific), a. DENV 2 infected and mock infected (a) HEK293T/17 cells and (b)
with Oil red O before observation under bright field of a Carl Zeiss
ts in HEK293T/17 cells are arrowed. The staining was repeated on cells
uted and quantified by spectrophotometry. Experiment was
<0.05)
Fig. 2 (See legend on next page.)
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Fig. 2 Profiles of lipid metabolism associated gene transcripts in response to DENV 2 infection of HEK293T/17 cells. HEK293T/17 cells were either
infected (grey bars) with DENV 2 or mock infected (white bars) and the transcripts of fatty acid synthase (FASN), acetyl CoA carboxylase alpha
(ACC1), adipose triglyceride lipase (ATGL), peroxisome proliferator activated receptor (PPARα), diglyceride acyltransferase (DGAT), fatty acyl CoA
oxidase (AOX), carnitine palmitoyltransferase I (CPT1), medium-chain acyl-CoA dehydrogenase (MCAD), sterol regulatory element-binding protein-
1c (SREBP1c) and stearoyl-CoA desaturase (SCD1) genes analyzed by real time PCR on days 1–3 p.i. Experiment was undertaken independently in
triplicate. Bars show mean +/−SD (*; p value <0.05)
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synthase (FASN) antibody (sc-55580; Santa Cruz Bio-
technology Inc.), a 1:1,000 dilution of a rabbit anti-ACC
monoclonal antibody (#3662; Cell Signaling Technology
Inc., Danvers, MA), a 1:2,000 dilution of a rabbit anti-
PPARγ polyclonal antibody (sc-7196; Santa Cruz Bio-
technology Inc.) or a 1:3,000 dilution of a goat anti-actin
polyclonal antibody (sc-1616; Santa Cruz Biotechnology
Inc.) before incubation with a 1:8000 dilution of a horse-
radish peroxidase (HRP) conjugated rabbit anti-mouse
IgG polyclonal antibody (Thermo Fisher Scientific), a
1:10,000 dilution of a HRP conjugated goat anti-rabbit
IgG (Pierce Rockford, IL) or a 1:8,000 dilution of HRP
conjugated rabbit anti-goat IgG polyclonal antibody
(31402; Pierce, Rockford, IL). Signals were detected
using the Amersham ECL plus Western Blotting Detec-
tion Reagents (GE Healthcare) and autoradiography film.Statistical analysis
Data were analyzed using the GraphPad Prism program,
statistical analysis of significance were undertaken by
paired-sample T Tests using SPSS statistic 17.0 (SPSS
Inc., Chicago, IL) with value of p < 0.05 for significance.
CC50 and EC50 values were calculated using the freeware
ED50plus (v1.0) software as described previously [29].Results
Lipids in DENV infection
To begin to investigate the involvement of lipids in
DENV infection we first focused on neutral triglycerides.
HEK293T/17 and HepG2 cells were therefore either
mock infected or infected with DENV 2, and at 24 h
post infection examined by light microscopy after stain-
ing with Oil Red O, a diazo dye that stains neutral tri-
glycerides. While neither of the examined cell types
examined showed large lipid droplets, both cell types
showed results consistent with the reduction of lipid
droplets as a consequence of infection (Fig. 1a, b) as
established by others [22]. The reduction in neutral tri-
glycerides was confirmed by elution of the dye, and
spectrophotometric quantitation (Fig. 1c), although the
difference between DENV infected at non-infected cells
was lost in HEK293T/17 cells at 36 h.p.i.Evaluation of lipid pathway gene transcripts
To evaluate the mRNA expression of genes involved in
lipid metabolism, the transcripts of genes mediating
lipogenesis (fatty acid synthase (FASN), acetyl CoA carb-
oxylase alpha (ACC1), sterol regulatory element-binding
protein-1c (SREBP1c), diglyceride acyltransferase
(DGAT) and stearoyl-CoA desaturase (SCD1)), lipolysis
(peroxisome proliferator activated receptor (PPARα) and
adipose triglyceride lipase (ATGL)) and fatty acid oxida-
tion (fatty acyl CoA oxidase (AOX), medium-chain acyl-
CoA dehydrogenase (MCAD) and carnitine palmitoyl-
transferase I (CPT1) were determined by quantitative
real time PCR in mock infected and DENV 2 infected
HEK293T/17 and HepG2 cells.
Results (Figs. 2 and 3) showed that the trend of gene
transcription was broadly similar for genes in both cell
lines, with transcripts significantly increasing at 24 h in
DENV 2 infected cells as compared to mock infected
cells, and levels of transcription generally decreasing
thereafter. Notable exceptions to this trend were
DGAT1, which in both cell lines showed a reduction in
gene transcription at 24 h in infected cells (Figs. 2 and
3), and a significant increase in gene transcription by
day 3 post-infection as compared to mock infected cells,
as well as the lipogenesis genes FASN and SREBP1c in
HEK293T/17 cells and the lipolysis gene ATGL in
HepG2 cells (Fig. 2 and 3). For the majority of genes that
showed an initial increase, all transcripts in HepG2 in-
fected cells showed reduced levels by day 3 post infec-
tion (below the level of mock infected cells), while for
HEK293T/17 cells, some transcripts still showed an in-
crease over mock by day 3 (PPARα, AOX and SCD1),
while others were either not different from mock at day
3 (ACC1, CPT1, MCAD) or significantly reduced as
compared to mock infected cells (FASN, ATGL,
SREBP1c). Combined however, the results (with some
exceptions) were consistent with a broad initial up-regu-
lation of lipid metabolism gene transcription, followed
by a decline in gene transcription over the next 2 to
3 days post infection.
Influence of serotype and passage history
The lipid gene transcription profile was repeated, this
time using a laboratory adapted DENV-4LAB, and a low
passage DENV 4 isolated from a dengue hemorrhagic
Fig. 3 (See legend on next page.)
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Fig. 3 Profiles of lipid metabolism associated gene transcripts in response to DENV 2 infection of HepG2 cells. HepG2 cells were either infected
(grey bars) with DENV 2 or mock infected (white bars) and the expression of fatty acid synthase (FASN), acetyl CoA carboxylase alpha (ACC1),
adipose triglyceride lipase (ATGL), peroxisome proliferator activated receptor (PPARα), diglyceride acyltransferase (DGAT), fatty acyl CoA oxidase
(AOX), carnitine palmitoyltransferase I (CPT1), medium-chain acyl-CoA dehydrogenase (MCAD), sterol regulatory element-binding protein-1c
(SREBP1c) and stearoyl-CoA desaturase (SCD1) genes analyzed by real time PCR on days 1–3 p.i. Experiment was undertaken independently in
triplicate. Bars show mean +/−SD (*; p value <0.05)
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17 cells were investigated. Results (Fig. 4) again showed a de-
gree of dysregulation of transcription of genes involved in
the different aspects of lipid metabolism (lipogenesis, lipoly-
sis and fatty acid oxidation), although there were marked dif-
ferences from the changes seen in response to DENV 2
infection, and indeed, differences were observed between
DENV-4LAB and DENV-4DHF, particularly on day 1 post
infection. While the majority of genes showed down-regula-
tion in transcription as compared to mock on days 2 and 3
post infection, discordant results were observed for three
genes, namely ATGL, mCAD1 and SREBP1c (Fig. 4).
Evaluation of lipid pathway protein expression
We further investigated changes in protein expression of
genes involved in lipid metabolism, and levels of three
proteins (ACC1, PPARγ and FASN) were determined by
western blotting on days 1 to 3 post infection after infec-
tion with DENV-4LAB and DENV-4DHF or mock infec-
tion. Results (Fig. 5) showed some alterations of
expression, although alterations in protein expression
level were not as marked as alterations in gene
expression.
DENV 2 infection of FASN silenced HEK293T/17 cells
The modulation of lipid metabolism associated gene ex-
pression during DENV infection suggests that this
process might be a suitable anti-DENV target. To ex-
plore this FASN, a critical enzyme in lipogenesis [30]
was down regulated through the use of siRNA. A panel
of four different siRNAs (FASN1 - FASN4) was initially
investigated for the ability to reduce FASN mRNA ex-
pression as assessed by real time PCR. Results showed
that two siRNAs (FASN1 and FASN4) were able to
largely abolish FASN expression on day 2 post transfec-
tion (Additional file 2: Figure S1), with no associated ef-
fects on cell viability (Additional file 2: Figure S2). Due
to the very low expression detected by real time PCR for
FASN1 and FASN4, the experiment was repeated inde-
pendently (Additional file 2: Figure S3) and results again
showed a dramatic reduction in expression with FASN1
but a more modest reduction for FASN4. To confirm
the lack of transcript seen with FASN 1, amplification
products for day 2 post transfection were additionally
run on agarose gels (Additional file 2: Figure S3). A sig-
nificant reduction in FASN protein expression aftersiRNA transfection was confirmed by western blotting
(Additional file 2: Figure S4). Subsequently HEK293T/17
cells were transfected with siRNAs directed against
FASN (FASN1 and FASN4) or against GFP, and on day 2
post transfection infected with DENV 2 in parallel with
non-siRNA treated cells and mock infected cells. On day
1 post infection, cells were analyzed for infection by flow
cytometry, and the supernatant examined for virus titer.
Results showed that the percentage of infection was sig-
nificantly reduced in FASN siRNA treated cells as com-
pared to siGFP or cells not treated with siRNA (Fig. 6),
and that virus titer was reduced by some 4Log10 in
FASN siRNA treated cells as compared to siGFP or cells
not treated with siRNA (Fig. 6).
Evaluation of anti-FASN drug treatment to inhibit DENV
infection
To evaluate the possibility of drug targeting towards
lipid metabolism as an anti-DENV therapy, one drug,
orlistat (tetrahydrolipstatin) was selected for evaluation.
Cell cytotoxicity towards HEK293T/17 cells was evalu-
ated using the MTT assay and cell morphology was add-
itionally observed under an inverted light microscope.
Results (Additional file 2: Figure S5) showed no cytotox-
icity at 24 h post treatment over the range of concentra-
tions tests (10 μM to 100 μM), and no discernible
changes in morphology over the same time period (Add-
itional file 2: Figure S6). However at 36 h post treatment,
while the MTT assay showed no significant difference
(Additional file 2: Figure S5), discernible morphological
changes with orlistat treatment above 50 μM were seen
(Additional file 2: Figure S6). The CC50 values were
1580 μM and 557 μM for orlistat at 24 and 36 h respect-
ively. The possibility of this drug having a direct viru-
cidal activity on DENV was additionally evaluated, and
no loss of either cell infectivity or virus titer produced
was observed after directly incubating DENV with the
drug before infection (Additional file 2: Figure S7).
HEK293T/17 cells were therefore incubated for 1 h in
the presence or absence of the drug before infection
with DENV 2 in the absence of the drug. Cells were cul-
tured under standard conditions in the presence or ab-
sence of the compound as appropriate, and at 24 or 36 h
post infection the percentage infection and virus titer
were determined. These early time points were selected
to avoid complications from the induction of apoptosis
Fig. 4 (See legend on next page.)
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Fig. 4 Profiles of lipid metabolism associated gene transcripts in response to infection of HEK293T/17 cells with DENV 4. HEK293T/17 cells were
either infected with a laboratory adapted DENV-4LAB (grey bars) or a low passage DENV-4DHF (black bars) as previously described [27] or mock
infected (white bars) and the expression of fatty acid synthase (FASN), acetyl CoA carboxylase alpha (ACC1), adipose triglyceride lipase (ATGL),
peroxisome proliferator activated receptor (PPARα), diglyceride acyltransferase (DGAT), fatty acyl CoA oxidase (AOX), carnitine palmitoyltransferase
I (CPT1), medium-chain acyl-CoA dehydrogenase (MCAD), sterol regulatory element-binding protein-1c (SREBP1c) and stearoyl-CoA desaturase (SCD1)
genes analyzed by real time PCR on days 1–3 p.i. Experiment was undertaken independently in triplicate. Bars show mean +/−SD (*; p value <0.05)
Tongluan et al. Virology Journal  (2017) 14:28 Page 10 of 18which occurs at later time points. Results at 24 h post
infection (Fig. 7a) show that while the percentage of in-
fected cells was not greatly reduced (albeit by a signifi-
cant amount), the virus titer was significantly reduced by
treatment with orlistat (Fig. 7b). At 36 h post infection,
the percentage of cells infected was reduced slightly but
significantly for orlistat treated cells (Fig. 7c) while virus
titers were reduced by nearly 3Log10 for orlistat at
10 μM (Fig. 7d). Because of the noted morphological
changes seen at higher concentrations of orlistat at 36 h,
virus titers were not evaluated for these concentrations.
The EC50 values for reduction of virus production for
orlistat were 84.79 μM and 10.07 μM at 24 and 36 h
respectively.
To determine if orlistat showed broad serotype and
strain type activity, HEK293T/17 cells were againFig. 5 Expression of lipid metabolism associated proteins in response to in
infected with a laboratory adapted DENV-4LAB (lab) or a low passage DEN
and (a) the expression of acetyl CoA carboxylase alpha (ACC), peroxisome
determined by western blotting together with actin. Experiments were und
show mean +/−SD (*; p value <0.05)incubated for 1 h in the presence or absence of the
100 μM of orlistat before infection with a laboratory
adapted DENV 4 (DENV-4LAB) or a low passage DENV
4 isolated from a dengue hemorrhagic fever patient
(DENV-4DHF) as previously described in the absence of
the drug. Cells were cultured under standard conditions
in the presence or absence of 100 μM orlistat as appro-
priate, and at 24 h post infection the percentage infec-
tion and virus titer were determined. Results (Fig. 7e, f )
showed a reduction in percentage infection for both vi-
ruses in the presence of the drug (Fig. 7e), and an ap-
proximately 2Log10 reduction in virus titers for the two
viruses (Fig. 7f ).
To determine the effect of the compound at lower
concentrations, the effect of the compound on DENV 2
viral production was examined between 1 and 10 μM.fection of HEK293T/17 cells with DENV 4. HEK293T/17 cells were either
V-4DHF (DHF) as previously described [27] or mock infected (Mock)
proliferator activated receptor (PPARγ) and fatty acid synthase (FASN)
ertaken independently in triplicate and signals quantitated (b). Bars
Fig. 6 DENV 2 infection of HEK293T/17 cells with down-regulated fatty acid synthase (FASN). HEK293T/17 cells were treated with siRNAs targeted
to FASN (FASN1 and FASN4) or a control siRNA (GFP) or not treated (DENV) and subsequently infected with DENV 2. At 24 h.p.i both percentage
infection and virus titer were determined. Experiments were undertaken independently in triplicate, with duplicate plaque assay. (a to d) representative
flow cytometry histograms with gating. M1: uninfected cell population, M2: infected cell population. Black line is mock infected (the same for all
histograms), a red: DENV infected, b siGFP transfected and DENV infected, c siFASN1 transfected and DENV infected, d siFASN4 transfected and
infected. e Bar chart showing M2 populations from three independent replicates and (f) bar chart showing results of plaque assay. Bars show mean
+/−SD (*; p value <0.05)
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reduction in virus titer, with significant reductions in
virus titer starting from 7 μM.
To determine if the effect of orlistat was due to effects
on viral entry, cells were not treated or pre-treated with
orlistat for 6 h, washed and infected with DENV 2. In
the first experiment, immediately after the infection
period the cells were harvested and the level of the
DENV viral genome established by qRT-PCR. Results
(Fig. 8a) showed no difference in levels of viral genome
between treated and non-treated cells, suggesting thatorlistat does not exert its effect though altering viral up-
take. In the second experiment cells were again pre-
treated for 6 h with orlistat, washed and infected with
DENV and then cultured under standard conditions
without the drug for 24 h before determining the per-
centage infection. Results (Fig. 8b) showed that there
was no difference in percentage infection when the cells
had only been pre-treated.
To further confirm that orlistat was acting during in-
fection and not at viral entry, cells were infected under
standard conditions and orlistat added to the medium at
Fig. 7 DENV 2 infection of HEK293T/17 cells treated with orlistat. HEK293T/17 cells were treated with the concentrations of orlistat as indicated or
not treated (DENV) and subsequently infected with DENV 2 (a-d, g) or DENV-4DHF or DEN-4LAB (e,f). At 24 (a, b, e, f, g) or 36 h.p.i (e,f) the percentage
infection and (a, c, e) and virus titer (b,c,d,g) were determined. Experiments were undertaken independently in triplicate, with duplicate plaque assay.
Bars show mean +/−SD (*; p value <0.05)
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centage infection were observed when the drug was
added at all time points post infection (Fig. 8c).
Effect of compounds on dengue protein expression
To determine the effects of the compounds on DENV
protein expression, HEK293T/17 cells grown on glass
cover slips were infected with DENV 2 and treated with
orlistat at a concentration of 10 μM. At 24 and 36 hpost-infection, cells were observed under a confocal
microscope for expression of DENV NS1 after staining
with an anti-NS1 antibody. Results (Fig. 9) showed no
observable reduction in NS1 signal with either com-
pound at either time point. We additionally observed ex-
pression of DENV NS3 protein, and, as studies have
shown that FASN is relocalized through interaction with
NS3 and colocalizes with NS3 [25] we undertook a
double staining to look at expression of both DENV
Fig. 8 DENV 2 infection of HEK293T/17 cells pre-and post-treated with orlistat. a, b HEK293T/17 cells were not treated or treated with orlistat for
6 h before washing and subsequent infection with DENV 2. Cells were either (a) immediately harvested post infection and the viral genome copy
number determined by qRT-PCR or (b) cultured for 24 h in the absence of the drug and percentage infection determined by flow cytometery.
c HEK293T/17 cells were mock infected or infected with DENV 2 before culture under standard conditions either without further treatement
(DENV) or with the addition of orlistat at the indicates times post-infection. At 24 h.p.i. cells were harvested for determination of percentage
infection by flow cytometry. Experiments were undertaken independently in triplicate. Bars show mean +/−SD (*; p value <0.05)
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duction in DENV NS3 expression in the presence of the
compounds, and, markedly, no significant colocalization
between DENV NS3 and FASN was observed (Pearsons
correlation coefficient 0.082 ± 0.03). We additionally tried
co-immunoprecipitation experiments to confirm the
interaction between NS3 and FASN, but despite repeated
attempts, we were unable to do so (data not shown).
To confirm the apparent lack of reduction of DENV pro-
tein expression under compound treatment, HEK293T/17
cells were again infected in the presence or absence of orli-
stat or mock infected, and expression of both structural
(DENV E protein) and non-structural (DENV NS3) pro-
teins as well as FASN were determined by western blotting
in parallel with determining expression of actin. Results
(Fig. 11) showed no change in levels of NS3 expression for
either drug, while levels of E protein were reduced to about
50% at the highest level of orlistat used (100 μM). The re-
sults are consistent with the observations taken under con-
focal microscopy in which the significant decrease in virus
output was not associated with a significant decrease in
DENV NS3 protein expression. Interestingly, a significant
reduction in FASN expression with DENV infection and
orlistat treatment was seen even with treatment at 10 μM
(Fig. 13).Discussion
Increasing attention is being focused on the role and in-
volvement of lipids in DENV infection, and several stud-
ies undertaken on samples from DENV patients have
shown that there are distinct changes in the lipidome of
DENV infected patients [31, 32]. This is supported by
studies that have shown lipid re-modeling in response to
DENV infection in both mammalian [22, 25] and insect
[17] cells. In mammalian cells it is believed that the
main consequence of activation of autophagy in DENV
infection [23, 24] is increased β-oxidation of fatty acids
[22] and that lipid remodeling is achieved through the
re-localization of FASN to the replication complex by
interaction with DENV NS3 [25, 26].
While we and others [22] show a reduction of lipid
droplets in response to DENV infection, other have re-
ported an increase in the number of lipid droplets [33,
34]. This is reflected in the conflicting roles proposed
for lipid droplets during DENV infection. While some
authors propose that lipid droplets represent an “energy
sink” that is tapped during viral replication [22], others
propose that lipid droplets serve as a binding site for the
DENV C protein during DENV assembly [35, 36]. Thus
the involvement of lipid droplets during DENV infection
requires further investigation.
Fig. 9 Effect of orlistat on DENV 2 NS1 expression. HEK293T/17 cells were pre-treated with 10 μM orlistat or not treated before mock infection or
infection with DENV 2. At (a) 24 or (b) 36 h.p.i cells were fixed and stained to show the nucleus (blue) and DENV 2 NS1 protein (red). Cells were
examined under an Olympus FluoView 1000 confocal microscope with 60× magnification. Representative, non-contrast adjusted merged images
are shown
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Fig. 10 Double staining for FASN and NS3. HEK293T/17 cells were pre-treated with 10 μM orlistat or not treated before mock infection or
infection with DENV 2. At (a) 24 or (b) 36 h.p.i cells were fixed and stained to show the FASN (green), DENV 2 NS3 protein (red) and nuclei (blue).
Cells were examined under an Olympus FluoView 1000 confocal microscope with 60× magnification. Representative, non-contrast adjusted
merged images are shown
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marked changes in expression of genes involved with
lipogenesis, lipolysis and fatty acid oxidation in response
to DENV infection, with the most common profile being
an early increase in expression, followed by a decrease in
expression over time. While this study used a targeted
pathway analysis, other studies using unbiased ap-
proaches have also identified lipid metabolism genes as
being differentially regulated. Sessions and colleagues
undertook a cross platform analysis of a number of stud-
ies and both FASN and DGAT1 were identified as being
differentially regulated [37]. The alterations in lipid geneexpression showed both cell type and virus strain varia-
tions, suggesting that there are differences in how differ-
ent viruses re-model lipid metabolism. This is consistent
with our previous observation that different DENV
strains modulate the host cell proteome largely inde-
pendently of virus serotype or passage history [27].
There was a large degree of discord between gene ex-
pression as evaluated at the level of the message and at
the level of the protein. However, a number of large
scale studies have clearly shown a high level of discord-
ance between mRNA and protein levels [38–41]. This is
attributed to a number of factors, particularly including
Fig. 11 Western blot analysis of DENV 2 structural and non-structural proteins. HEK293T/17 cells were treated with the concentrations of orlistat
as indicated or not treated (DENV) and subsequently mock infected (mock) or infected with DENV 2. At 24 h.p.i the expression of (a) DENV 2 E
and NS3 proteins and (d) FASN was determined by western blotting. All filters were stripped and re-probed with actin as a loading control.
Experiments were undertaken independently in triplicate and signals quantitated (b, c, e). Bars show mean +/−SD (*; p value <0.05)
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large scale modulation of transcription, there was a
much smaller effect on protein levels, suggesting a rela-
tively large and stable protein pool associated with lipid
metabolism. As such it is difficult to assess the biological
relevance of the slight reduction in protein levels seen as
a consequence of infection.
In contrast to the observations of others [25], we did
not find a significant level of colocalization of FASN
with NS3, and we were not able to confirm an inter-
action between these two proteins in immunoprecipita-
tion experiments (data not shown). It is possible that
this interaction is mediated by viral factors including
virus strain. Importantly however, we have shown here
that β-oxidation is not the only lipid metabolism path-
way affected, but alterations in gene expression were
additionally observed in lipogenesis and lipolysis.
Reduction of FASN through siRNA mediated knock
down affected both virus titer as well as the percentage
of infected cells, while orlistat mainly affected virus titer,
with only minimal effects on the percentage of cells in-
fected. This would suggest that knock down of FASN
before infection results in a cellular environment un-
suited to the establishment of infection, possibly by al-
tering endosomal trafficking or another process required
to establish the infection [17]. Another possibility is that
lack of FASN may inhibit the formation of the DENV in-
duced membranous structures [20] that serve to shield
the DENV dsRNA from the host cell interferon response
[21] again resulting in a more significant effect on
DENV replication than simple biochemical inhibition of
FASN. We note however that the knockdown of FASNwas very transient which suggests that there is a high
level of transcription of this gene, even under conditions
of infection. However, confirming this would require ab-
solute quantification of transcript levels rather than the
comparative analysis undertaken here.
While siRNA mediated knock down of FASN had a
larger effect on both virus production and percentage in-
fection that treatment with orlistat, there is a less clear
path to application in the treatment of DENV patients
with siRNA based therapies than for the already licensed
orlistat, and therefore evaluation of the effects of knock
down of FASN by siRNA on DENV infection were less
comprehensive than the studies undertaken with orlistat.
Treatment of cells with orlistat significantly reduced
viral titer, albeit again with some strain related variation.
Interestingly, while no significant reduction in NS3
levels was observed E protein expression was reduced to
about 50% in orlistat treated cells. This suggests that the
biochemical inhibition of FASN (as opposed to knock
down) results in a reduction of the ability of viral parti-
cles to correctly form and be exported from the cells.
This would support the contention of Kuhn and co-
workers [25] that the major effect of lipid re-modeling in
DENV infection is to influence membrane architecture
to facilitate viral formation and egress. However, the re-
duction of E protein expression observed under orlistat
treatment suggests that additional mechanisms are in-
volved with this drug which may involve the specific
clearance of E protein from the infected cell. Interest-
ingly, a much greater reduction of FASN expression was
seen in cells that were treated with orlistat and infected,
as compared to cells that were only infected. This might
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is a faster turnover of non-functional proteins.
Orlistat predominantly has activity against FASN
expressed in the cells of the gut, and acts to reduce dietary
fat uptake, hence its applications to the treatment of obes-
ity.[42] However, some orlistat is available systemically
[43, 44], suggesting possible application in anti-DENV
therapy. The need for further exploration of orlistat as a
potential anti-dengue therapy has been proposed [45].
However the EC value of orlistat is in the μMolar range,
suggesting that other, more potent compounds targeting
to FASN or other modulators of lipid metabolism [46] will
be of better application. For example previous studies of
the FASN inhibitor C75 have shown a CC50 value of
>100 μM and an EC50 value of 5.7 μM [47] and an ap-
proximately 2Log10 reduction in viral titer [25].
Conclusions
Increasing attention has been paid to the role of
lipids and lipid metabolism during DENV infection
[22, 25, 26, 31–34, 36, 45–48] and to methods of
targeting components of this cellular process as an
anti-DENV therapy. This study has confirmed that
there is dysregulation of expression of lipid metabolism
associated genes in DENV infection, although the effect
on protein expression is markedly more muted, possibly
as a reflection of protein turnover times. Interference with
FASN, whether through knock down or chemical interfer-
ence had a marked effect on viral output, although again
there was some disconnect with the expression of non-
structural proteins, suggesting that one of the main effects
of alterations in lipid metabolism is on the ability of the
virus particle to form as proposed by others [25]. Overall
this work supports earlier studies and highlights the utility
of further investigations on modulating lipid metabolism
as a viable ant-DENV therapeutic approach.Additional files
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Additional file 2: Figure S1. Real-time PCR validation of siRNA mediated
gene silencing of fatty acid synthase (FASN) gene. HEK293T/17 cells were not
treated (mock) or treated with a siRNA control (GFP) or treated with one of
four siRNAs directed to FASN (FASN1 to FASN 4). On days 1 to 5 post
transfection the level of FASN transcript was determined by real time PCR.
Normalization expression data relative to actin is shown. Bars show mean
+/−SD. (a) 1 day post transfection, (b) 2 days post transfection, (c) 3 days post
transfection, (d) 4 days post transfection and (e) 5 days post transfection. Bars
show mean +/−SD (*; p value <0.05). Figure S2. Assessment of cell viability
after siRNA transfection. HEK293T/17 cells were not treated (mock) or treated
with a siRNA control (GFP) or treated with siRNAs directed to FASN (FASN1
and FASN 4). On day 2 post transfection cell viability was assessed by trypan
blue staining and counting cells using a hemocytometer. Bars show mean
+/−SD. Figure S3. Real-time PCR validation of siRNA mediated gene silencing
of fatty acid synthase (FASN) gene. HEK293T/17 cells were not treated (mock)
or treated with a siRNA control (GFP) or treated with one of four siRNAs di-
rected to FASN (FASN1 to FASN 4). On day 2 post transfection (a) the level ofFASN transcript was determined by real time PCR and (b) amplification prod-
uct was run on an agarose gel and products visualized after ethidium bromide
staining. Normalization expression data relative to actin is shown. Bars show
mean +/−SD (*; p value <0.05). Figure S4. Western analysis of FASN expres-
sion after siRNA treatment. HEK293T/17 cells were not treated (mock) or
treated with a siRNA control (GFP) or treated with one of four siRNAs directed
to FASN (FASN1 to FASN 4). On days 1 to 4 post transfection the level of FASN
protein was determined by western blot analysis. Normalization expression
data relative to actin is shown. Bars show mean +/−SD (* p value <0.05; ** p
value <0.01). Figure S5. Determination of orlistat cytotoxicity to HEK293T/17
cells. HEK293T/17 cells were incubated with different concentrations of orlistat
or not treated (−) for (a) 24 h or (b) 36 h followed by MTT cell viability assays.
Data is derived from 8 replicates. Treatment with 5% DMSO was used as a
positive control. Bars show mean +/−SD (*; p value <0.05). Figure S6. The
morphology of HEK293T/17 cells after orlistat treatment. HEK293T/17 cells
were incubated with different concentrations of orlistat or not treated (mock)
for (a) 24 h or (b) 36 h followed by observation under an inverted microscope.
Magnification × 20. Figure S7. Evaluation of virucidal activity of orlistat. Stock
DENV-2 was incubated with orlistat at concentrations of 1, 10, 20, 50 μM for
1 h and then used in the standard infection protocol. At 24 h.p.i (a) flow cy-
tometry was performed to determine the percentage of infection and (b) su-
pernatants were used to determine the virus titers. No deficit was observed in
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